Counselors in Oxford, CT Accepting Medicare
7 Counselors found. Showing 1 - 7
 Alice Kroll, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 420 Quaker Farms Rd, Oxford, CT 06478 Phone: 203-305-1012 Fax: 203-888-5275 |
Stephanie Pavlo, LPC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 350 Center Rock Grn Ste 9, Oxford, CT 06478 Phone: 203-951-1858 Fax: 203-951-1857 |
Ms. Lucrezia Mangione, LCPC,LPC,NCC,BC-TMH Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 160 Christian St, Oxford, CT 06478 Phone: 802-578-3700 |
Brittney Romagna, MA, LPCA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 160 Christian St Ste 7, Oxford, CT 06478 Phone: 802-578-3700 |
 William Bogen Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 14 Skyline Dr, Oxford, CT 06478 Phone: 203-881-5539 |
Jenna Rae Ryan Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 350 Center Rock Grn Ste 9, Oxford, CT 06478 Phone: 203-951-1858 Fax: 203-307-1771 |
Theresa Alecia Rose Counselor - Professional Medicare: Medicare Enrolled Practice Location: 350 Center Rock Grn Ste 9, Oxford, CT 06478 Phone: 860-532-8222 |
News Archive
Active or passive food preparation can increase hunger and motivation to eat
Food preparation (both actively preparing food yourself as well as watching others) can lead to eating more, a new study in the journal Appetite reports.
3SBio, Ascentage Pharma announce cancer therapeutics collaboration
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, and Ascentage Pharma Group Corporation, Ltd. ("Ascentage Pharma") announced today that they have formed a strategic alliance to research, develop and commercialize best-in-class targeted cancer therapeutics focusing on programmed cell death, or apoptosis. The alliance will leverage Ascentage Pharma's expertise in structure-based small molecule design, lead optimization and preclinical development with 3SBio's proven drug development and commercialization capabilities in China.
Copy number variants linked with 'schizophrenia-like' subtype of bipolar disorder
A form of rare genomic structural variation called copy number variants (CNVs) may be more closely associated with schizophrenia than bipolar disorder.
U.S. FDA approves Gilead's Truvada to minimize risk of sexually-acquired HIV infection
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truto reduce the risk of sexually-acquired HIV infection in adults at high risk.
› Verified 3 days ago
Occupational Therapists
Counselors
Pharmacists
Clinical Social Workers
Marriage Counselors
Dentists